Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid A is the highly conserved, hydrophobic anchor of lipopolysaccharide (LPS) situated within the outer leaflet of the outer membrane of Gram-negative bacteria. It is widely recognized as the 'endotoxin' responsible for the potent inflammatory response associated with Gram-negative bacterial infections. Biologically, Lipid A is essential for bacterial viability and membrane stability, but it also serves as a primary pathogen-associated molecular pattern (PAMP) that triggers the human innate immune system through the TLR4/MD-2 receptor complex. In clinical medicine, Lipid A is a critical therapeutic target for polymyxin antibiotics, which bind directly to the molecule to disrupt bacterial membrane integrity. However, the overstimulation of the immune system by Lipid A can lead to lethal sepsis and septic shock, making its neutralization or the inhibition of its biosynthetic pathway (such as the LpxC enzyme) a major focus for drug development against multi-drug resistant pathogens.
Drugs like polymyxins bind to the negatively charged phosphate groups of Lipid A via electrostatic interactions, displacing divalent cations (Mg2+ and Ca2+) that stabilize the outer membrane. This displacement leads to membrane disorganization, increased permeability, and eventual cell lysis. Other agents, such as Eritoran, act as competitive antagonists at the TLR4/MD-2 complex, mimicking the structure of Lipid A to prevent endotoxin-induced signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial lipopolysaccharide lipid A (Lipid A).